# FDA Inspection 1176430 - Lexamed, Ltd - August 04, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/lexamed-ltd/67bf6191-e42c-445a-ba51-e1970bfa2f1b
Source feed: FDA_Inspections

> FDA Inspection 1176430 for Lexamed, Ltd on August 04, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1176430
- Company Name: Lexamed, Ltd
- Inspection Date: 2022-08-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 955062 - 2015-11-05](https://www.globalkeysolutions.net/records/fda_inspections/lexamed-ltd/114d4a74-c122-4f6f-9598-f14dde7c09cc)
- [FDA Inspection 572516 - 2009-03-13](https://www.globalkeysolutions.net/records/fda_inspections/lexamed-ltd/87115cf8-0de1-471e-856b-9dfb606045c5)

Company: https://www.globalkeysolutions.net/companies/lexamed-ltd/b54f148c-75ae-4ec5-aee3-d675b90f3f88

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c